Early use of tocilizumab in solid organ transplant recipients with COVID‐19: A retrospective cohort study in Saudi Arabia

BACKGROUND: Tocilizumab was studied to reduce cytokine syndrome in patients with severe COVID‐19 pneumonia in solid organ transplant (SOT) recipients with conflicting results. We aim to study the early use of tocilizumab in SOT with COVID‐19 pneumonia on low flow oxygen. METHODS: This is a retrospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamani, Amani H., Alraddadi, Basem M., Almaghrabi, Reem S., Amer, Afnan A., Mehdawi, Fatimah S., AL‐Hamzi, Mohammed A, Aldajani, Meshari S., Alattas, Majda S., Elsaed Ramadan, Aiman M., Wali, Ghassan Y, Alshukairi, Abeer N., Al Mutair, Abbas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926500/
https://www.ncbi.nlm.nih.gov/pubmed/35029324
http://dx.doi.org/10.1002/iid3.587